Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women

American Journal of Epidemiology

Volumn 167, Issue 9, 2008, Pages 1059-1069

  Moorman, Patricia G ^a   Calingaert, Brian ^a   Palmieri, Rachel T ^b   Iversen, Edwin S ^c   Bentley, Rex C ^a   Halabi, Susan ^a   Berchuck, Andrew ^a   Schildkraut, Joellen M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b IL   (United States)

^c Duke University   (United States)

Author keywords

Case control studies; Contraceptives, oral; Menopause; Ovarian neoplasms; Pregnancy

Indexed keywords

HORMONE; ORAL CONTRACEPTIVE AGENT;

AGE STRUCTURE; CANCER; CONTRACEPTIVE USE; DISEASE INCIDENCE; HEALTH RISK; HORMONE; PREGNANCY; REGRESSION ANALYSIS; RISK FACTOR; TUMOR;

ADULT; AGED; AGING; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HORMONAL REGULATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; REPRODUCTION; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; UNITED STATES;

ADULT; AGED; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; LOGISTIC MODELS; MIDDLE AGED; NORTH CAROLINA; OVARIAN NEOPLASMS; PARITY; POSTMENOPAUSE; PREGNANCY; PREMENOPAUSE; REGISTRIES; RISK FACTORS;

NORTH AMERICA; NORTH CAROLINA; UNITED STATES;

EID: 42649096613     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwn006     Document Type: Article

References (26)

1. Ries LAG, Melbert D, Krapcho M, et al, eds. SEER cancer statistics review, 1975-2004. Bethesda, MD: National Cancer Institute. (http://seer.cancer. gov/csr/1975_2004/). Based on November 2006 SEER data submission, posted to the SEER website, 2007.
2. Riman T, Nilsson S, Persson IR. Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies. Acta Obstet Gynecol Scand 2004;83:783-95.
3. Fathalla MF. Incessant ovulation - a factor in ovarian neoplasia? Lancet 1971;2:163.
4. Fleming JS, Beaugié CR, Haviv I, et al. Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: revisiting old hypotheses. Mol Cell Endocrinol 2006;247:4-21.
5. Siskind V, Green A, Bain C, et al. Beyond ovulation: oral contraceptives and epithelial ovarian cancer. Epidemiology 2000;11:106-10.
6. Gwinn ML, Lee NC, Rhodes PH, et al. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 1990;43:559-68.
7. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 1998;23:1774-86.
8. Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev 2005;14:98-107.
9. Murdoch WJ, Van Kirk EA. Steroid hormonal regulation of proliferative, p53 tumor suppressor, and apoptotic responses of sheep ovarian surface epithelial cells. Mol Cell Endocrinol 2002;186:61-7.
10. Bu SZ, Yin DL, Ren XH, et al. Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer 1997;79:1944-50.
11. Rodriguez GC, Walmer DK, Cline M, et al. Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Investig 1998;5:271-6.
12. Tung KH, Wilkens LR, Wu AH, et al. Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis. Am J Epidemiol 2005;161:321-9.
13. Fairfield KM, Willett WC, Rosner BA, et al. Obesity, weight gain and ovarian cancer. Obstet Gynecol 2002;100:288-96.
14. Titus-Ernstoff L, Perez K, Cramer DW, et al. Menstrual and reproductive factors in relation to ovarian cancer risk. Br J Cancer 2001;84:714-21.
15. Albrektsen G, Heuch I, Kvåle G. Reproductive factors and incidence of epithelial ovarian cancer: a Norwegian prospective study. Cancer Causes Control 1996;7:421-7.
16. Whiteman DC, Siskind V, Purdie DM, et al. Timing of pregnancy and the risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2003;12:42-6.
17. Cooper GS, Schildkraut JM, Whittemore AS, et al. Pregnancy recency and risk of ovarian cancer. Cancer Causes Control 1999;10:397-402.
18. Beehler GP, Sekhon M, Baker JA, et al. Risk of ovarian cancer associated with BMI varies by menopausal status. J Nutr 2006;136:2881-6.
19. Kuper H, Cramer DW, Titus-Ernstoff L. Risk of ovarian cancer in the United States in relation to anthropometric measures: does the association depend on menopausal status? Cancer Causes Control 2002;13:455-63.
20. Moorman PG, Schildkraut JM, Calingaert B, et al. Ovulation and ovarian cancer: a comparison of two methods for calculating lifetime ovulatory cycles (United States). Cancer Causes Control 2002;13:807-11.
21. McKnight B, Cook LS, Weiss NS. Logistic regression analysis for more than one characteristic of exposure. Am J Epidemiol 1999;149:984-92.
22. Chiaffarino F, Parazzini F, Negri E, et al. Time since last birth and the risk of ovarian cancer. Gynecol Oncol 2001;81:233-6.
23. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US casecontrol studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1212-20.
24. Willett WC, Bain C, Hennekens CH, et al. Oral contraceptives and risk of ovarian cancer. Cancer 1981;48:1684-7.
25. Tworoger SS, Fairfield KM, Colditz GA, et al. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol 2007;166: 894-901.
26. Moorman PG, Newman B, Millikan RC, et al. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 1999;9:188-95.